Cromos Pharma, where the patients are

Awards & Advancement

Novella Clinical announces new leadership roles

Tuesday, September 10, 2013 12:00 PM

Three senior executives of CRO Novella Clinical have assumed new leadership roles within the organization.

More... »

CRF Health eCOA webinar series

AMRI announces executive leadership changes

Tuesday, September 10, 2013 10:01 AM

CRO Albany Molecular Research has announced Thomas E. D'Ambra, Ph.D., will retire as president and chief executive officer, effective Dec. 31. D'Ambra will be named non-executive chairman of the board of directors on the same date.

More... »


Michael Seiden named CMO for McKesson Specialty Health, U.S. Oncology Network

Friday, September 6, 2013 03:09 PM

McKesson Specialty Health and The U.S. Oncology Networkhave appointed of Michael V. Seiden, M.D., Ph.D. as chief medical officer.

More... »

Sensus Healthcare appoints Mark Nestor clinical director

Wednesday, September 4, 2013 04:02 PM

Sensus Healthcare has appointed Dr. Mark Nestor clinical director. Nestor joins a panel of medical advisory board members. He will lead the company's efforts in training, education and clinical research as the company continues to expand its SRT technology for non-invasive skin cancer treatment for NMSC as well as treatment for Keloid scars.

More... »

Karen M. Emmons named VP, director of Kaiser Foundation Research Institute

Wednesday, September 4, 2013 04:00 PM

Kaiser Permanente, a health research organization, has named Karen M. Emmons, Ph.D., associate dean for research at the Harvard School of Public Health, vice president for research and director of the Kaiser Foundation Research Institute, effective Sept. 30.

More... »

Quintiles receives Computerworld Data+ Editor's Choice Award

Thursday, August 29, 2013 01:00 PM

CRO Quintiles has been recognized for its pioneering work creating big data solutions that help pharmaceutical organizations improve their probability of success throughout the drug development process, with a Computerworld Data+ Editor's Choice Award for its Quintiles Infosario platform.

More... »

Rho awarded for workplace effectiveness, flexibility

Thursday, August 29, 2013 12:00 PM

CRO Rho has received the 2013 Alfred P. Sloan Award for Excellence in Workplace Effectiveness and Flexibility. 

More... »

Ambrx names Peter Kiener chief scientific officer

Wednesday, August 28, 2013 02:42 PM

Ambrx, a clinical stage biopharmaceutical company, has appointed Peter Kiener, Ph.D., chief scientific officer. Kiener has experience in the development of next-generation biologic therapeutics, including multi-specific, antibody based biologics, while president, chief executive officer and cofounder of Zyngenia.

Kiener led Zyngenia through its early stages of development, including validating the technology platform, identifying and advancing lead programs and securing Series A funding. Previously, Kiener was the executive vice president and global head of biologics R&D at MedImmune, AstraZeneca's biologics arm. He built protein and antibody engineering capabilities and oversaw the submission of multiple INDs and NDAs. Over the previous 18 years, Kiener held multiple positions at Bristol-Myers Squibb, 10 of which were spent working on biological therapeutics.

More... »

Sticares InterACT receives French research tax credit approval

Monday, August 26, 2013 12:11 PM

Sticares InterACT, an internationally operating contract service provider specializing in cardiovascular and metabolic diseases, has been awarded the French research tax credit approval, which it has been holding since 2009. This approval has now been extended for the years 2013, 2014 and 2015.

More... »

Patricia Monteforte named president of Trio Clinical Resourcing

Wednesday, August 21, 2013 04:40 PM

Aptiv Solutions, a global biopharmaceutical and medical device development services company, has appointed Patricia Monteforte president of Trio Clinical Resourcing, an Aptiv Solutions subsidiary focused on clinical and regulatory staffing. Monteforte will leverage more than 25 years in the pharmaceutical industry and success leading CROs to assemble teams of clinical and regulatory professionals to deliver flexible resourcing solutions to meet the current and future challenges in the pharmaceutical and medical device industry.

More... »

CenterWatch Drugs in Clinical Trials
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

April 14

Proposal calls for back-to-back trials to measure efficacy and effectiveness prior to FDA approval

Study: Minority populations under-represented in cancer trials, but have higher rates of incidence

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

April

Make way for mobile health in clinical trials
Despite patient retention, data quality benefits, regulatory hurdles persist

Global clinical trial laboratories decentralize
Regional labs reducing complexity, delivering cost and time savings

Already a subscriber?
Log in to your digital subscription.

Purchase the April issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

March

Strategic alliances hit bumps in the road
Mixed relationship performance driving new approaches

Tapping community hospitals for clinical trial volunteers
New study finds high potential but infrastructure, resources are lacking

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs